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Monitoring trends in cancer incidence is essential if high 
quality cancer services are to be maintained and resourced. 
Trends for all cancers (excluding NMSC) along with the most 
common cancers are analysed in detail. Additionally 
projections of cancer incidence up to the year 2035 are 
presented for the first time in Northern Ireland. 
 
The full report is available at www.qub.ac.uk/nicr 
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PROJECTED INCIDENCE RATES FROM 2015 TO 2035 
Incidence rates of cancer among men are projected to remain 
steady in future years with no change by 2020, while by 2035 a 
slight drop of 1% is expected.  
 
Among women incidence rates are projected to increase, with 
a 7% rise by 2020 and a 13% rise by 2035 expected.  
PROJECTED CHANGE IN INCIDENCE RATES BY SEX AND TYPE 
 Compared to the 2009-2013 average male incidence rates are projected to:  
- decrease by more than 20% by 2035 for stomach, bladder and prostate cancers,  
- increase by more than 20% by 2035 for melanoma, oral, liver and kidney cancers. 
 
Also compared to the 2009-2013 average female incidence rates are projected to:  
- decrease by more than 20% by 2035 for stomach and cervical cancers; 
- increase by more than 20% by 2035 for melanoma, oral, uterine, liver, kidney, pancreatic, 
lung and breast cancer. 
PROJECTED NUMBER OF CASES DIAGNOSED FROM 2015 TO 2035 
In 2009-2013 there were 4,347 male and 4,275 female cases of 
cancer (ex. NMSC) diagnosed each year.  
 
By 2020 the number of cases is expected to rise by 25% for men 
and by 24% for women to 5,443 male and 5,285 female cases. 
 
By 2035 the number of cases is expected to rise by 65% for men 
and by 63% for women to 7,181 male and 6,967 females cases.  
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Year of diagnosis
Male
Prediction interval
Female
Prediction interval
ACTUAL  PROJECTED 
CANCER TYPE 
Male Female 
2009-13 
cases 
per year 
2020 2035 2009-13 
cases 
per year 
2020 2035 
Cases per year  
(prediction interval) 
Cases per year  
(prediction interval) 
Cases per year  
(prediction interval) 
Cases per year  
(prediction interval) 
All (ex. NMSC) 4,425 5,443 (5140, 5746) 7,181 (6675, 7687) 4,351 5,285 (5050, 5520) 6,967 (6590, 7344) 
Bladder 150 169 (128, 210) 205 (162, 248) 61 67 (47, 87) 83 (62, 104) 
Brain 81 94 (67, 121) 110 (76, 144) 55 63 (42, 84) 75 (49, 101) 
Breast 1,268 1,589 (1464, 1714) 2,077 (1888, 2266) 
Cervix 103 93 (56, 130) 74 (26, 122) 
Colorectal 680 909 (807, 1011) 1,292 (1143, 1441) 545 688 (605, 771) 946 (818, 1074) 
Kidney 173 244 (195, 293) 368 (294, 442) 115 161 (124, 198) 246 (189, 303) 
Leukaemia 116 137 (101, 173) 170 (128, 212) 80 91 (66, 116) 116 (88, 144) 
Liver 72 110 (77, 143) 179 (125, 233) 31 43 (24, 62) 67 (33, 101) 
Lung 649 816 (717, 915) 1,128 (991, 1265) 484 641 (570, 712) 923 (821, 1025) 
Melanoma 138 215 (168, 262) 370 (288, 452) 181 239 (193, 285) 317 (244, 390) 
NHL 175 226 (182, 270) 316 (257, 375) 150 180 (146, 214) 232 (191, 273) 
Oesophagus 127 163 (124, 202) 215 (165, 265) 65 72 (52, 92) 86 (63, 109) 
Oral 140 204 (157, 251) 288 (204, 372) 73 103 (73, 133) 146 (96, 196) 
Ovary 158 178 (143, 213) 223 (183, 263) 
Pancreas 105 135 (98, 172) 185 (139, 231) 116 156 (125, 187) 241 (198, 284) 
Prostate 1,039 1,183 (1040, 1326) 1,294 (1082, 1506) 
Stomach 141 143 (107, 179) 140 (106, 174) 81 78 (56, 100) 76 (56, 96) 
Uterus 238 343 (286, 400) 506 (411, 601) 
NHL: Non-Hodgkin’s lymphoma, NMSC: Non-melanoma skin cancer 
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Cancer incidence trends 1993-2013 
with projections to 2035 
David Donnelly1 & Anna Gavin1 
1 Northern Ireland Cancer Registry, Centre for Public Health, Mulhouse Building, Grosvenor Road, Belfast BT12 6DP  
Methods 
Data on all cancers (excluding NMSC) diagnosed during1993-2013 was extracted from the 
NI Cancer Registry. Age-specific rates for all cancers combined and 30 common cancers 
were determined for both sexes by year of diagnosis. The data was fitted separately for 
ages 0-49, 50-59, 60-69, 70-79 and 80+ using a regression model with five-year age group, 
five-year birth cohort and year of diagnosis used as predictors of the cancer incidence rate. 
The resulting model was used to predict rates in future years, which were combined with 
population projections to provide estimates of the future number of cases.  
Male Female 
FACTORS THAT CAN INFLUENCE INCIDENCE PROJECTIONS 
 
Changes to risk factor exposure within the general population. 
Risk factors likely to have the greatest impact on future projections are: 
oTobacco use; 
oExcessive alcohol consumption; 
oObesity, lack of physical activity and/or lack of a balanced diet; 
oUltraviolet radiation from sunshine or sun beds. 
 
Introduction of health service initiatives that aim to either prevent or 
diagnose cancer early. 
These include vaccinations (e.g. the HPV vaccination), screening (e.g. the 
breast, cervical and colorectal screening programmes) and diagnostic 
tests (e.g. PSA testing for prostate cancer). 
 
Changes to cancer classification or revisions to population projections. 
PROJECTED NUMBER OF CASES DIAGNOSED BY SEX AND TYPE IN 2020 AND 2035 
The number of cases diagnosed each year is projected to increase for all cancer types, except 
for stomach cancer, and cervical cancer. 
 
By 2035 case volume is expected to more than double for liver, kidney and oral cancers, for 
female uterine and pancreatic cancers and for male melanoma. 
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CONCLUSION: The increasing number of cancer cases will result in an increased 
burden on health services. However the largest increases are projected for 
cancers such as melanoma that are largely preventable. The opportunity thus 
exists to reduce the projected increase through preventative measures. 
